XML 63 R39.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Equity Investees (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Equity Method Investments and Joint Ventures [Abstract] |
Schedule of Consolidated Financial Statements Related To Equity Investees | The following table presents information included in our Consolidated Financial Statements related to our equity investees:
| Year Ended December 31,
| 2023 |  | 2022 |  | 2021
Genesis’ share of operating earnings | $ | 80,461 |  |  | $ | 68,469 |  |  | $ | 73,389 |
Amortization of differences attributable to Genesis’ carrying value of equity investments | (14,263) |  |  | (14,263) |  |  | (15,491) |
Net equity in earnings | $ | 66,198 |  |  | $ | 54,206 |  |  | $ | 57,898 |
Distributions earned(1) | $ | 90,833 |  |  | $ | 75,406 |  |  | $ | 84,106 |

X
- Definition Represents the share of equity investment earnings included in the consolidated statement of operations less the amortization of the excess purchase. The table also includes distributions received from equity method investments. + References No definition available. + Details
Name: | gel_ConsolidatedFinancialStatementsRelatedToEquityInvesteesTableTextBlock
Namespace Prefix: | gel_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration